In Vitro Diagnostics market was valued at $61.65 billion in 2015 and is expected to reach $94.57 billion, growing at a CAGR of 6.3% during 2022
ReportsWeb.com published “In Vitro Diagnostics Global Market” from its database. This report Strategic recommendations in key business segments based on the market estimations. This report Supply chain trends mapping the latest technological advancements.
(EMAILWIRE.COM, January 03, 2018 ) According to Publisher, the Global In Vitro Diagnostics market is accounted for $61.65 billion in 2015 and is expected to reach $94.57 billion by 2022 growing at a CAGR of 6.3%. Technologically advanced healthcare and consumer spending in market is helping the market growth. Polluted environment and contaminated surroundings are leading to increase in number of chronic disease and infections, these all factors are favoring the market to grow. Moreover widely spread knowledge and cost effectiveness are also driving the market. But stringent regulations and reimbursement issues are hampering the market growth.
However Infectious disease in application segment is anticipated to grow at considerable pace due to rise in amount of infectious diseases and it is followed by HIV/AIDS application. Whereas Laboratories in end-user segment is estimated to grow fast because of rise in number of laboratories, followed by Point of Care Diagnostics. North America being the largest revenue market, Asia Pacific is expected to grow fast due to increasing number of End-User applications.
For more information about this report: http://www.reportsweb.com/in-vitro-diagnostics-global-market-outlook-2015-2022
Some of the major key players in the market are Roche Diagnostics Bio-Rad Laboratories, Inc., Johnson and Johnson , Biomérieux, Siemens Healthcare, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Cepheid Inc , Alere Inc., Novartis and Leica Biosystems.
Applications Covered:
-Diabetes
-Autoimmune Diseases
-Cardiology
-Drug Testing
-HIV/AIDS
-Infectious Diseases
-Nephrology
-Oncology/Cancer
-Other Applications
Product & Services Covered:
-Data Management Software/Hardware
-Instruments
-Reagents & Kits
-Services
Technologies Covered:
-Immunochemistry/Immunoassays
-Elisa
 Chemiluminescence Immunoassays (CLIAs)
 Colorimetric Immunoassays (CI)
 Fluorescence Immunoassays (FIA)
-Western Blot
-Rapid Tests
-Radioimmunoassay's (RIA)
-Elispot
-Coagulation and Hemostasis
-Molecular Diagnostics (MDX)
-DNA Sequencing & Next-Generation Sequencing
-Hybridization
-Isothermal Nucleic Acid Amplification Technology (INAAT)
-Microarrays
-Polymerase Chain Reaction (PCR)
-Other Molecular Diagnostics
-Hematology
-Microbiology
-Clinical Chemistry
-Electrolyte Panels
-Basic Metabolic Panel
-Lipid Profiles
-Liver Panels
-Renal Profiles
-Specialty Chemical Tests
-Thyroid Function Panels
-Other Technologies
End-Users Covered:
-Academic Institutes
-Hospitals
-Laboratories
-Patient Self-Testing
-Point-Of-Care Testing
-Other End-Users
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001322804/sample
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
11.1 Roche Diagnostics
11.2 Bio-Rad Laboratories, Inc.
11.3 Johnson and Johnson
11.4 Biomérieux
11.5 Siemens Healthcare
11.6 Abbott Laboratories, Inc.
11.7 Thermo Fisher Scientific, Inc.
11.8 Ortho Clinical Diagnostics, Inc.
11.9 Danaher Corporation
11.10 Sysmex Corporation
11.11 Becton, Dickinson and Company
11.12 Cepheid Inc
11.13 Alere Inc.
11.14 Novartis
11.15 Leica Biosystems
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001322804/buying
However Infectious disease in application segment is anticipated to grow at considerable pace due to rise in amount of infectious diseases and it is followed by HIV/AIDS application. Whereas Laboratories in end-user segment is estimated to grow fast because of rise in number of laboratories, followed by Point of Care Diagnostics. North America being the largest revenue market, Asia Pacific is expected to grow fast due to increasing number of End-User applications.
For more information about this report: http://www.reportsweb.com/in-vitro-diagnostics-global-market-outlook-2015-2022
Some of the major key players in the market are Roche Diagnostics Bio-Rad Laboratories, Inc., Johnson and Johnson , Biomérieux, Siemens Healthcare, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Cepheid Inc , Alere Inc., Novartis and Leica Biosystems.
Applications Covered:
-Diabetes
-Autoimmune Diseases
-Cardiology
-Drug Testing
-HIV/AIDS
-Infectious Diseases
-Nephrology
-Oncology/Cancer
-Other Applications
Product & Services Covered:
-Data Management Software/Hardware
-Instruments
-Reagents & Kits
-Services
Technologies Covered:
-Immunochemistry/Immunoassays
-Elisa
 Chemiluminescence Immunoassays (CLIAs)
 Colorimetric Immunoassays (CI)
 Fluorescence Immunoassays (FIA)
-Western Blot
-Rapid Tests
-Radioimmunoassay's (RIA)
-Elispot
-Coagulation and Hemostasis
-Molecular Diagnostics (MDX)
-DNA Sequencing & Next-Generation Sequencing
-Hybridization
-Isothermal Nucleic Acid Amplification Technology (INAAT)
-Microarrays
-Polymerase Chain Reaction (PCR)
-Other Molecular Diagnostics
-Hematology
-Microbiology
-Clinical Chemistry
-Electrolyte Panels
-Basic Metabolic Panel
-Lipid Profiles
-Liver Panels
-Renal Profiles
-Specialty Chemical Tests
-Thyroid Function Panels
-Other Technologies
End-Users Covered:
-Academic Institutes
-Hospitals
-Laboratories
-Patient Self-Testing
-Point-Of-Care Testing
-Other End-Users
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001322804/sample
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
11.1 Roche Diagnostics
11.2 Bio-Rad Laboratories, Inc.
11.3 Johnson and Johnson
11.4 Biomérieux
11.5 Siemens Healthcare
11.6 Abbott Laboratories, Inc.
11.7 Thermo Fisher Scientific, Inc.
11.8 Ortho Clinical Diagnostics, Inc.
11.9 Danaher Corporation
11.10 Sysmex Corporation
11.11 Becton, Dickinson and Company
11.12 Cepheid Inc
11.13 Alere Inc.
11.14 Novartis
11.15 Leica Biosystems
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001322804/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results